San Francisco – September 15, 2026 -- Shareholder rights firm Hagens Berman is investigating International Business Machines Corporation (NYSE: IBM) for potential securities law violations after CEO Arvind Krishna disclosed a Q2 2026 earnings shortfall on July 14, 2026 that wiped out over $68 billion in market capitalization in a single trading day, sending IBM shares down 25%.

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Regeneron Pharmaceuticals (NASDAQ: REGN) after the failure of a Phase 3 melanoma trial wiped out $11 billion in market capitalization. The suit covers investors who purchased Regeneron shares between August 1, 2025, and May 15, 2026, with a lead plaintiff deadline set for September 14, 2026.

San Francisco – September 10, 2026 -- A securities class action has been filed against PROCEPT BioRobotics Corporation (NASDAQ: PRCT), alleging the company inflated handpiece sales through an undisclosed bulk-discount program that pulled forward demand and masked deteriorating customer inventory levels. Law firm Hagens Berman Sobol Shapiro LLP is representing investors who purchased PROCEPT stock between February 28, 2024 and February 25, 2026, with a lead plaintiff deadline set for September 22, 2026.

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities class action against Cogent Communications Holdings (NASDAQ: CCOI), alleging the company misrepresented its optical wavelength "backlog" as a reliable indicator of revenue growth between February 29, 2024 and May 1, 2026.

San Francisco – September 10, 2026 -- Wix.com Ltd. (NASDAQ: WIX) is now the target of a securities class action following a 27% plunge in its share price after the company disclosed Q1 2026 results showing operating expenses had spiked 46% year-over-year. The case, Yappi v. Wix.com Ltd., et al., No. 26-cv-08852, was filed in the U.S. District Court for the Northern District of Illinois and seeks to represent investors who bought Wix securities between February 19, 2025 and May 12, 2026.

San Francisco – September 10, 2026 -- Investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) have until September 28, 2026, to seek lead plaintiff status in a securities class action tied to the company's Duchenne muscular dystrophy therapy, deramiocel, as the FDA extends its review timeline.

SAN FRANCISCO – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has expanded a securities fraud class action against Pentair plc (NYSE: PNR), extending the class period back to March 11, 2025, from the original start date of April 28, 2026. The lead plaintiff deadline is set for October 2, 2026, giving investors who purchased Pentair stock during the newly expanded window until that date to seek appointment as lead plaintiff.

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action against Alibaba Group Holding Limited (NYSE: BABA), alleging the company concealed ties to China's Ministry of Industry and Information Technology (MIIT) and engaged in unauthorized AI model theft. The case, Wistisen v. Alibaba Group Holding Limited, et al., No. 1:26-cv-06654, is filed in the U.S. District Court for the Southern District of New York.

San Francisco – September 10, 2026 -- Hagens Berman Sobol Shapiro LLP has opened an investigation into Aardvark Therapeutics, Inc. (NASDAQ: AARD) over allegations that the company misled investors about the safety of its lead drug candidate ARD-101, ahead of an October 13, 2026 deadline for shareholders to seek lead plaintiff status in a pending securities class action.

San Francisco – September 10, 2026 -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain executives now face a securities class action after a July 29, 2026 federal complaint from the Federal Trade Commission wiped over $970 million from the company's market capitalization in a single trading session, sending shares down $4.32, or 14.7%.